By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ovid Therapeutics 

205 East 42nd Street

New York  New York   10017  U.S.A.
Phone: 212-776-4381 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Ovid


Start Up

Company News
Ovid Receives Orphan Drug Designation From The FDA For OV101 For The Treatment Of Patients With Angelman Syndrome 9/8/2016 11:22:43 AM
Ovid Announces Participation In Two Upcoming Investor Conferences 9/1/2016 10:53:35 AM
Ovid Expands Leadership Team And Scientific Advisory Board 4/13/2016 11:29:29 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
Ovid Announces Election Of Industry Leader Douglas E. Williams, Ph.D., To Its Board Of Directors 1/22/2016 6:43:36 AM
What You Need to Know About Ovid 12/2/2015 11:42:42 AM
Ovid Announces Election Of Bart Friedman To Its Board Of Directors 11/24/2015 9:25:09 AM
Ovid Announces Appointment Of Dr. Anna Kazanchyan To Senior Vice President, Business Development 10/15/2015 8:19:48 AM
Former Teva (TEVA) CEO Banks $75 Million for Neurology Startup Ovid 8/11/2015 10:40:28 AM
Ovid Appoints Dr. Jeremy Levin As Chief Executive Officer 4/16/2015 12:32:06 PM